Literature DB >> 7300106

Pharmacokinetics of amikacin in children with normal and impaired renal function.

J M Lanao, A A Dominguez-Gil, A Dominguez-Gil, S Málaga, M Crespo, F Santos.   

Abstract

The pharmacokinetics of the antibiotic amikacin sulfate were studied in eight children with normal renal function and in ten children with varying degrees of renal impairment. All patients received a single i.v. dose of 7.5 mg/kg of the antibiotic. Amikacin follows a two-compartment open-kinetic model. The serum half-life, which in children with normal renal function has an average value of 1 hour, reached values of 14 hours in children with severe renal impairment. A lineal relationship is established between the beta constant and the creatinine clearance (Clcr) according to the equation beta = 0.001 + 0.005.Clcr, with r = 0,818. From thie equation, the dosage interval is modified to maintain the serum concentrations of the antibiotic within the therapeutic interval.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7300106     DOI: 10.1038/ki.1981.112

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical Models.

Authors:  Iftekhar Mahmood; Carl-Michael Staschen
Journal:  AAPS J       Date:  2016-01-22       Impact factor: 4.009

2.  Anti-infective Medicines Use in Children and Neonates With Pre-existing Kidney Dysfunction: A Systematic Review.

Authors:  Chiara Minotti; Elisa Barbieri; Denis Doni; Cristina Impieri; Carlo Giaquinto; Daniele Donà
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.569

3.  Dosing Recommendations for Pediatric Patients With Renal Impairment.

Authors:  Amer Al-Khouja; Kyunghun Park; Daijha J C Anderson; Caitlyn Young; Jian Wang; Shiew Mei Huang; Mona Khurana; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2020-06-15       Impact factor: 3.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.